LC-MS3 quantification of O-glycopeptides in human serum

scientific article published on 24 July 2013

LC-MS3 quantification of O-glycopeptides in human serum is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ELPS.201200658
P932PMC publication ID3808000
P698PubMed publication ID23765987

P2093author name stringRadoslav Goldman
Petr Pompach
Julius Benicky
Miloslav Sanda
P2860cites workMembrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cellsQ24601584
Mucins in cancer: protection and control of the cell surfaceQ28235006
Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database searchQ28731567
SISCAPA peptide enrichment on magnetic beads using an in-line bead trap deviceQ30487950
Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serumQ36280125
A human proteome detection and quantitation projectQ37210681
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammationQ37223561
Mammalian glycosylation in immunityQ37290930
Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.Q37295526
Glycosylation as a strategy to improve antibody-based therapeuticsQ37402407
Metabolism, cell surface organization, and diseaseQ37671886
Complex genetic regulation of protein glycosylationQ37679726
Glycan labeling strategies and their use in identification and quantification.Q37708129
Recent advances in the MS analysis of glycoproteins: Theoretical considerationsQ37822366
The Tn antigen-structural simplicity and biological complexityQ37831859
The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validationQ38012171
Protein O-glycosylation analysisQ38040264
Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell linesQ39461034
HemopexinQ39568334
Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopesQ41201112
Intracellular distribution of haem after uptake by different receptors. Haem-haemopexin and haem-asialo-haemopexinQ42866847
Protein glycosylation analysis by HILIC-LC-MS of Proteinase K-generated N- and O-glycopeptidesQ43133934
Micro- and macroheterogeneity of N-glycosylation yields size and charge isoforms of human sex hormone binding globulin circulating in serumQ43736758
Fibrinogen alpha chain O-glycopeptides as possible markers of urinary tract infection.Q44669026
Determination of site-specific glycan heterogeneity on glycoproteinsQ47650180
The elimination of O-linked glycans from glycoproteins under non-reducing conditionsQ72366219
Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serumQ84746102
P433issue16
P304page(s)2342-2349
P577publication date2013-07-24
P1433published inElectrophoresisQ3050608
P1476titleLC-MS3 quantification of O-glycopeptides in human serum
P478volume34

Reverse relations

cites work (P2860)
Q39373031Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring
Q31131930Data Independent Analysis of IgG Glycoforms in Samples of Unfractionated Human Plasma.
Q36957711Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities
Q37278723Increased sialylation of site specific O-glycoforms of hemopexin in liver disease.
Q34464343Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease
Q35085189Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease
Q48230257Study of structure-dependent chromatographic behavior of glycopeptides using reversed phase nanoLC.
Q38293204Targeted methods for quantitative analysis of protein glycosylation

Search more.